Medicines pages
-
-
PageSearch for medicines allowed to be supplied in Australia, medicine ingredients and safety information.
-
SectionFind out how to get a medicine or medical device into the ARTG so you can legally sell it in Australia.
More information
- Medicines
- How we regulate medicines
- Medicines and TGA classifications
- Registered medicines
- Australia's medicine labels are becoming clearer
- Tamper-evident packaging
- PI/CMI search facility
- Medicines Repurposing Program - Eligibility criteria and prioritisation considerations
Dispose of unwanted medicines
Health professionals
University student education materials
Latest alerts
-
Medicine shortage alertsA shortage of Bicillin L-A 1.2 million unit prefilled syringes is anticipated from 20 December 2024 to 10 January 2025. A PBS-listed substitute product is available.
-
Medicine shortage alertsPharmacists may dispense alternative brands or strengths without a new prescription.
-
Safety alertsThe oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.
Latest articles
-
Product Information safety updates - November 2024
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information. -
Promethazine hydrochloride (Phenergan) not to be used in children under 6
Safety updatesHealth professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age. -
TGA and InstantScripts reach settlement
Media releasesThe TGA has settled judicial review proceedings brought by InstantScripts in respect of infringement notices issued to it by the TGA.
Latest publications
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
PublicationsRead our 2024 stakeholder survey report, which aims to improve the way we work with our stakeholders.
-
Summary report of residual DNA and endotoxin on CoVID-19 mRNA vaccines conducted by TGA Laboratories
TGA laboratory testing reportsThe TGA has conducted a comprehensive evaluation of the residual DNA and endotoxin levels in the two mRNA vaccines supplied in Australia - Comirnaty (Pfizer) and Spikevax (Moderna).
Latest consultations
-
ConsultationWe are seeking feedback on proposed improvements to TGA’s regulatory framework for medicine shortages and discontinuations in Australia.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), meeting of the Advisory Committee on Chemicals Scheduling (ACCS), or a joint meeting of these two committees.
-
ConsultationWe are seeking feedback on the proposed temporary labelling exemptions for paracetamol.